3 years ago

Re-classifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation.

Christine F Wogan, Naveen Garg, Osama Mawlawi, Jay P Reddy, Eric Rohren, Joseph D Khoury, Hubert Chuang, Jillian Gunther, Eleanor M Osborne, Zeinab Abou Yehia, Mani Akhtari, Sarah A Milgrom, Bouthaina S Dabaja, Yasuhiro Oki, Therese Y Andraos, Wenli Dong, Michelle Fanale, Grace L Smith, Chelsea C Pinnix
The presence of bulky disease in Hodgkin lymphoma (HL), traditionally defined with a 1-dimensional measurement, can change a patient's risk grouping and thus the treatment approach. We hypothesized that 3-dimensional measurements of disease burden obtained from baseline (18)F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) scans, such as metabolic tumor volume (MTV) and total lesion glycolysis (TLG), would more accurately risk stratify patients. To test this hypothesis, we reviewed pretreatment PET-CT scans of patients with stage I-II HL treated at our institution between 2003-2013. Disease was delineated on pre-chemotherapy PET-CT scans by two methods: 1) manual contouring, and 2) sub-thresholding of these contours to give the tumor volume with SUV≥2.5. MTV and TLG were extracted from the threshold volumes (MTVt, TLGt), as well as from the manually contoured soft-tissue volumes (MTVst, TLGst). At a median follow-up time of 4.96 years for the 267 patients evaluated, 27 patients were diagnosed with relapsed or refractory disease and 12 patients died. Both MTVt and TLGt were highly correlated with freedom from progression (FFP) and were dichotomized with 80th percentile cut-off values of 268 and 1703, respectively. Consideration of MTV and TLG enabled re-stratification of early-unfavorable HL patients as having low-risk and high-risk disease. We conclude that MTV and TLG provide a potential measure of tumor burden to aid in risk stratification of early unfavorable HL patients.

Publisher URL: http://doi.org/10.1182/blood-2017-04-773838

DOI: 10.1182/blood-2017-04-773838

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.